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Abstract
Every mammalian life develops from one cell after fertilization of an egg by the
sperm.

The molecular pathways governing this event are still poorly understood.

Numerous reports indicate that mammalian eggs highly express various protein kinase C
(PKC) isoforms. Accordingly, we hypothesize that PKC activity in the egg plays an
important role during egg-sperm membrane binding and fusion. In this study, we tested
our hypothesis in mouse gametes using two types of PKC inhibitors (calphostin c and
staurosporine) and the typical PKC activator, phorbol ester 12-tetradecanoylphorbol-13
acetate (PMA). After treatment with the individual drug, eggs were inseminated with
sperm. The sperm binding number (SB) and fusion rate (FR) were scored using light and
fluorescence microscopy. By applying the Student’s t-test, we confirmed that the FR and
SB were significantly decreased after PKC activator or inhibitors treatments. All treatment
groups, 1 µM calphostin c, 1 µM staurosporine, or 1 nM PMA showed the significant
reduction of FR and SB. Further analysis indicated that the inhibition effects of calphostin
c and PMA were dose- and time- dependent.

Moreover, under scanning electron

microscopy (SEM), we observed that the number and shape of microvilli on the PMAtreated eggs, but not on the calphostin c-treated eggs, was severely changed. Taken
together, these results suggest that egg PKC activity plays an important role in the
signaling regulation of sperm-egg membrane binding and fusion during fertilization.
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Chapter One
Introduction
The inability to conceive is not abnormal in the United States. About 15 % of
couples suffer from infertility (53). This problem stems form various factors such as low
sperm count or motility, prevention of the egg from being fertilized and delivered to the
uterus, sexually transmitted diseases, and so forth. Because more people tend to have
children at older ages, the risk of the infertility is expected to be larger (53). In vitro
fertilization is one of the common solutions for these infertile couples, however, it is
anticipated, from new findings in this study area, that more simple solutions will be sought.
All mammalian life begins to develop after sperm-egg membrane fusion. The
fertilized egg is implanted on the uterus of the maternal body, starts cell division, and
develops into an embryo. The conception requires several steps in the maternal body
including sperm-egg recognition and union, the fertilized egg’s trip though the fallopian
tube to the uterus, and the implantation.
Although these steps are shared by most mammals, the fertilization mechanism of
the sperm and egg has barely been examined at a molecular level until now.

The

interaction of the sperm and an egg is the first event to start this series of processes. By
understanding this initiation process at the molecular level, we can determine the important
proteins and signals involved. Although both the sperm and the egg are responsible for
this fertilization stage, this study was focused on the egg. The egg is one of the largest
cells in the mammalian body, therefore, it is possible to observe the localization of specific
molecules and treat with specific drugs on a single egg. For this study, many eggs had to
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be isolated at one time. Thus, the mammal chosen for investigating fertilization must have
certain characteristics. It should be small, easy to manage, and have enough eggs to be
isolated. In this respect, CD-1 mice (common name ICR, known as Institute of Cancer
Research) were purchased from Charles River labs (Wilmington, Massachusetts).
Identifying key molecules involved in sperm-egg membrane interaction is an
intensive research area in the field of reproductive biology. Much progress has been made
during the last decade. CD9, a member of tetraspanin membrane proteins, on the egg
membrane (63) and Izumo, which is a novel immunoglobulin superfamily protein, on the
sperm membrane (44) are two factors directly required for binding and fusion of the sperm
and an egg. These two proteins are the only two proven requirements for these steps, even
though an interaction of these two proteins is not reported thus far. CD9 is mainly
expressed on the microvillus region of the egg plasma membrane (46). This microvillus
region is the place where the sperm and an egg membrane interaction is mediated (25).
Without CD9 and Izumo, the sperm and the egg cannot fuse with each other and
conception will not be initiated. Despite these advancements, the signaling pathways
inside the sperm and the egg are barely understood thus far. For this study we focused on
one signaling pathway inside the egg, the protein kinase C (PKC) signaling. PKC is a
superfamily of protein kinases which phosphorylate many other proteins and regulate their
functions. The PKC superfamily consists of many isoforms divided into four subgroups,
conventional PKC (cPKC), novel (nPKC), atypical PKC, and PKC related kinase (PRK)
(27, 62). Several PKC isoforms have been reported in the egg (62). PKC activity is
known to have an important role for egg meiosis resumption, egg activation, and further
modification of eggs into zygotes (27, 44, 48). Many reports suggest involvement of
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different PKC isoforms during egg activation, but only cPKC is proven to be involved in
the step. Although it is known that cPKC activation leads to further development of the
egg, any significant function of cPKC activity as well as other subgroups in the egg during
fertilization and initiation of egg activation remains to be explored.
Calcium ion (Ca2+) plays an important role during mammalian egg activation.
After fertilization, we can observe repetitive intracellular Ca2+ increase in an egg (35, 45,
82). Calcium concentration in cytoplasm is repetitively and transiently raised after sperm
fusion to an egg (16, 81). This calcium oscillation causes cortical granule exocytosis,
which results in fertilization envelope formation (50). This protein layer makes a physical
barrier that prevents further sperm fusion to the egg. Actin is involved in the modification
of the egg after fertilization and interacts with PKC alpha, one isoform of cPKC (22). A
recent study by Halet and his colleagues (36) also shows the close relationship between
cPKC and calcium oscillation. From their research, it is expected that the long-term
calcium level may be maintained by cPKC activity (36). Because the vigorous activity of
PKC has been demonstrated inside the egg, we hypothesize that PKC is also involved in
gamete membrane binding and fusion. To determine the importance of PKC activity
during sperm-egg fertilization, various PKC activators and inhibitors were used to treat the
mouse eggs. The ability of fusion and binding of the egg was then tested by in vitro
fertilization (IVF). The collected results will determine the role, if any, of specific PKC
isoforms in the sperm-egg binding and/or fusion. Moreover, PKC activity is expected to
regulate actin-supported microvilli and CD9 which is localized on microvilli and
physically attached by PKC on the egg (46, 55, 98). The morphological structure of the
egg plasma membrane will also be viewed by scanning electron microscopy after drug
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treatment.
This experiment aims specifically at the sperm-egg binding and fusion. So the
eggs used in this experiment are zona-free eggs, which zona pellucida is chemically
removed from the egg. Zona pellucida is the polymers of three glycoproteins forming the
gel layer around the egg (24, 73). It induces acrosome reaction on the sperm and allows
the sperm to go through this jelly layer (23, 64). It also protects the egg from multiple
fertilizations by sperm (polyspermy) (92). To observe the pure interaction of sperm and
egg membrane, we removed this outer layer. So the sperm binding and fusion number is
not affected by the functions of zona pellucida.
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Objectives
The objectives of this study are: 1) to determine the fertilization ability of zonafree mouse eggs after PKC activation or inhibition inside the eggs; 2) to determine whether
there is an alteration of structure and localization of actin, CD9, chromosomal DNA, and
microvilli after PKC activation or inhibition in the zona-free mouse egg. Regulation of
PKC is thought to play a critical role in the egg’s ability to bind and fuse with the sperm.
Clarifying the effects of PKC activation and inhibition in the egg will further our
understanding of the egg’s signaling pathways during fertilization.
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Specific Aims
PKC is involved in meiosis resumption and further egg activation. It is also the
key regulator for biological activities of many target proteins in a cell. PKC is expected to
have an important role during fertilization. Therefore, the goal of this study is to determine
any alteration of fertilization ability of the mouse egg when PKC is activated or inhibited,
and to determine any alteration of the structures of the important molecules (actin, CD9,
chromosomal DNA, and microvillus) of the egg during fertilization.

Specific Aim 1
To determine the effects of PKC activation or inhibition in the mouse egg during
gamete membrane interaction.
Hypothesis: PKC activation or inhibition blocks sperm binding and
fusion to the egg.

Specific Aim 2
To determine the molecular and structural alternations in the mouse egg after PKC
activation or inhibition.
Hypothesis: Both PKC activation and inhibition change the
localization and the extent of some fertilization-related molecules and
structures.
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Chapter Two
Review of Literature
INTRODUCTION
This chapter briefly reviews reported studies about this area of research. The
sections are consisted of three parts:
One: Important molecules participating in sperm-egg membrane interaction and
further embryonic development
Two: Protein kinase C (PKC) as the important signaling molecules inside the egg
during egg activation
Three: CD-1 (ICR) mice as an experimental model for the investigation of IVF

Important molecules participating in sperm-egg membrane interaction and further
embryonic development
The molecular and cellular mechanisms underlying sperm-egg fertilization have
begun to be unfolded in the last two decades and still are being extensively explored.
Since this event consists the interaction of two kinds of cells, studies on both the sperm and
the egg are necessary to understand this phenomenon. First of all, the acrosome reaction
(AR) is the process by which the sperm acquires the fertilization competency.

AR

modifies the sperm membrane proteins and the sperm membrane, thus enables the sperm to
fertilize an egg (72). The freshly ejaculated sperm is unable to fertilize without undergoing
AR (72). This process is initiated when a sperm attaches to the zona-pellucida of the egg
in vivo. It also can occur spontaneously after 2 hours capacitation in a suitable culture
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medium in vitro (37, 84). This process is required for the sperm to penetrate though the
zona pellucida of the egg by producing nitric oxide synthase (NOS) (11). NOS enhances
the motility and AR of sperm which allow the sperm to fertilize with egg the effectively
(38, 74). On the other hand, oocytes undergo maturation steps inside the maternal body,
but their meiosis is arrested at the second metaphase (MII). When oocytes reach this phase,
they are defined as “egg” (59). The MII eggs do not experience further activation without
sperm fusion. Several key cellular events follow sperm-egg fusion, activation of the egg,
resumption of the egg meiosis, pronuclear formation, and initiation of the early embryonic
development, among others.
However, little is known about fertilization at the molecular level. To date, only
two proteins are known to be required factors during sperm-egg fusion, Izumo on the
sperm membrane and CD9 on the egg membrane. A Japanese research group recently
reported that sperm from Izumo-knockout male mice are infertile (44). Sperm from Izumo
knockout mice cannot fuse with the egg in vitro, thus proving that the Izumo protein on the
sperm membrane is essential for sperm fusion with the egg. The gene encoding Izumo was
identified from crude sperm protein by gel electrophoresis and immunoblotting. A human
homologue was an unverified gene in the National Centre for Biotechnology Information
(NCBI) database. The predicted protein size was 56.4 kDa on mouse sperm and 37.2 kDa
on human sperm. This protein was detectable only after the AR of the sperm.
CD9 knockout mice were also generated but only CD9 knockout females were
infertile (18). The eggs from CD9 knockout female mice cannot be fused with sperm in
vitro (34). CD9 is a member of the tetraspanin family. Proteins in this family have four
transmembrane domains. Zhu and colleagues (99) reported the requirement of the large
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Using microinjection, injection of Izumo

knockout sperm into a wild type egg or wild-type sperm into a CD9 knockout egg resulted
in normal egg activation and further development of the resulting embryo to term. The
derived offspring had no physical difference from wild-type mice (18, 44). Therefore,
these two proteins are currently confirmed as required molecules (fusion factors)
specifically involved in the process of sperm-egg fusion. These data indicate that each is
necessary but not that the pair alone is sufficient for fertilization.
The discovery of these two important molecules involved in fertilization has led to
further questions. What are the signaling pathways that regulate these molecules? What
signaling pathways are activated or inhibited after fertilization? To explore these questions,
we focused on PKC activity in mouse eggs. Because an egg is one of the biggest single
cells in an organism, molecular localization and structural changes can be observed and
analyzed with simple instruments. Zona pellucida is the final mechanical barrier to sperm
(6). Because of this property, we need to remove zona pellucida for certain observation of
sperm-egg membrane interaction.

Protein kinase C (PKC) as an important signaling pathway during egg activation
PKC is a family of serine/threonine kinases, which are enzymatic proteins that
phosphorylate other target proteins to stimulate their cellular activity (47, 66).

PKC

comprises four subgroups based on differences in activation sites (86). The four subgroups
are as follows: conventional PKCs (cPKC: PKCα, PKC β and PKCγ), atypical PKCs
(aPKC: PKCδ, PKCε, PKCη, and PKCθ), novel PKCs (nPKC: PKCζ, PKCι, and PKCλ),
and PKC-related kinases (PRK). These subgroups are regulated by multiple activators
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including calcium ion, diacylglycerol, and phosphatidylserine (Fig. 1-1).

Many

mechanisms and signaling pathways involving PKC activity have been described (76, 97).
One reason for studying PKC is that it is targeted by diacylglycerol and
phosphatidylserine, which are components of the cellular membrane. Because fertilization
is completed by gamete membrane interaction (gamete membrane binding and fusion) the
involvement of PKC activity is a strong possibility. Moreover, one previous study (98)
showed the association of PKC and CD9 after classical PKC activation by phorbol 12myristate 13-acetate (PMA). Therefore, PKC activity may contribute to the signaling
pathway(s) in the egg during sperm-egg membrane binding and fusion.
Many studies have investigated the significance of PKC activity in oocyte
maturation and egg activation. Before oocyte is completely matured to a secondary oocyte,
meiosis has to be resumed and prophase I to be finished (29). Germinal vesicle breakdown
(GVBD) is one of the important steps during the final stage of oocyte maturation. PKC
activation of mouse oocytes inhibit GVBD (26), but PKC activation by 12-myristate 13acetate (PMA) stimulates further egg activation at the MII stage (58). Early events of
oocyte activation, e.g., second polar body emission and pronuclear formation, are
restrained after inhibition of PKC activity (27). Furthermore, most PKC isoforms are
required for egg activation and the early stage of embryonic development (19, 27, 49).
These findings indicate important and very complex activities of PKC during oocyte
maturation and egg activation. Although this signaling pathway has been investigated in
many studies, PKC activity in the regulation of sperm-egg membrane binding and fusion
has not been explored.
There are many commercially available PKC activators and inhibitors. PMA and
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1,2-Dioctanoyl-sn-glycerol (DiC8) are used as PKC activators, and calphostin c,
staurosporine, (R)-(+)-trans-4-(1-Aminoethyl)-N-(4-Pyridyl) cyclohexane carboxamide
dihydrochloride (Y-27632), 12-(2-Cyanoethyl)-6,7,12,13-tetrahydro-13-methyl-5-oxo-5Hindolo(2,3-a) pyrrolo (3,4-c)-carbazole (Gö 6976), and 2-[1-(3-Dimethylaminopropyl)-5methoxyindol-3-yl]-3-(1H-indol-3-yl) maleimide (Gö 6983) are used as PKC inhibitors.
These chemicals target different PKC isoforms, so that the specific PKC isoform(s) playing
an important role during fertilization of mouse gametes may be identified.

Hiroto Akabane

12

Regulatory Domain

N

5/3/2006

Catalytic Domain

cPKC (α β γ)

)

DAG binding site

Ca2+ binding site

ATP binding site
Substrate Binding Site

nPKC (δ ε η θ)
DAG binding site

aPKC (ζ ι λ)
phosphatidylserine binding site

PRK
Rho (GTPase) binding site

Figure1-1. Schematic structures of four PKC subgroups.
Each group has distinct regulatory and catalytic domains. To be activated, cPKC requires
DAG and calcium ion; nPKC requires DAG; aPKC requires phosphatidylserine; and PRK
requires Rho. ATP is an obligatory factor for all PKC isoforms to be stimulated.
(DAG: Diacylglycerol)
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Figure 1-2. The structure of Phorbol 12-myristate 13-acetate (68).
It activates traditional PKC subgroups (cPKC and ｎPKC) by binding DAG
binding site (80).

Figure 1-3. The structure of 1,2-Dioctanoyl-sn-glycerol (1).

It activates traditional PKC subgroups by binding DAG binding site (80)
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Figure 1-4. The structure of calphostin c (13).
It is from Fungi Cladosporium cladosporioides, activated by light and a very
specific PKC activator (13).

Figure 1-5. The structure of staurosporine (79).
It is from bacteria Streptomyces sp. It inhibits many protekin kinases inside a
cell (39, 71).
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Figure 1-6. The structure of 12-(2-Cyanoethyl)-6,7,12,13-tetrahydro-13-methyl-5-oxo-5Hindolo(2,3-a) pyrrolo (3,4-c)-carbazole (Gö 6976) (30).
It is known to inhibit cPKC activity, but other subgroups are potentially inhibited (51, 77).

Figure 1-7. The structure of 2-[1-(3-Dimethylaminopropyl)-5-methoxyindol-3-yl]-3-(1Hindol-3-yl) maleimide (Gö 6983) (34).
It is known to inhibit PKC activity except PRK (34).

Figure 1-8. The structure of (R)-(+)-trans-4-(1-Aminoethyl)-N-(4-Pyridyl) cyclohexane
carboxamide dihydrochloride (Y-27632) (96).
It is known to inhibit PRK activity by binding ATP binding site (96).
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CD-1 (ICR) mice as an experimental model for the investigation of in vitro fertilization
Sperm-egg membrane binding and fusion are shared by all mammals as the part of
reproduction event. To explore the underlying mechanisms, it is required that we can
obtain enough numbers of eggs as needed from the animal. We also need to consider
husbandry and fecundity of the animal. ICR (Institute of Cancer Research, where this
mouse strain was developed) mice from Charles River Laboratories were used as the
experimental model in this research. This strain was Swiss origin and established in 1926
from 9 albino mice by Dr. Clara Lynch (83). Mating and breeding of this strain results in
more pups at a time comparing with normal non-albino mouse strain. Generally speaking,
each ICR mouse can ovulate about 25 eggs after being injected with pregnant mares’ serum
gonardotropin (PMSG) and human chorionic gonardotropin (hCG) in our laboratory.
Sacrificing 6 mice at each experiment, we were able to collect at least 60 eggs, which were
enough to make more than 3 groups of experiments with more than 15 eggs per group.
Thus, this experimental model is one of the best animal models to facilitate this
fertilization research.
In our experiments, 8-week old ICR mice were purchased from the commercial
vendor and normally spent 2 weeks in the animal facility of Marshall University to
accommodate the new environment before being used for egg isolation. We injected two
hormones PMSG and hCG into the mice to stimulate ovulation. The best egg numbers
were obtained from the oviducts of the mice that were sacrificed 13.5 hours after hCG
administration, which should be given at 47.5 after first PMSG injection. When the mice
were sacrificed more than 14 hours after hCG injection, we had problems to remove zona
pellucida from the eggs.

Hiroto Akabane

17

5/3/2006

All animal care and use procedures described within were reviewed and approved
by the Institutional Animal Care and Use Committee of Marshall University, and were
performed in accordance with the Guiding Principles for the Care and Use of Laboratory
Animals.
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Abstract
Every mammalian life develops from one cell after fertilization of an egg by the
sperm.

The molecular pathways governing this event are still poorly understood.

Numerous reports indicate that mammalian eggs highly express various protein kinase C
(PKC) isoforms. Accordingly, we hypothesize that PKC activity in the egg plays an
important role during egg-sperm membrane binding and fusion. In this study, we tested
our hypothesis in mouse gametes using two types of PKC inhibitors (calphostin c and
staurosporine) and the typical PKC activator, phorbol ester 12-tetradecanoylphorbol-13
acetate (PMA). After treatment with the individual drug, eggs were inseminated with
sperm. The sperm binding number (SB) and fusion rate (FR) were scored using light and
fluorescence microscopy. By applying the Student’s t-test, we confirmed that the FR and
SB were significantly decreased after PKC activator or inhibitors treatments. All treatment
groups, 1 µM calphostin c, 1 µM staurosporine, or 1 nM PMA showed the significant
reduction of FR and SB. Further analysis indicated that the inhibition effects of calphostin
c and PMA were dose- and time- dependent.

Moreover, under scanning electron

microscopy (SEM), we observed that the number and shape of microvilli on the PMAtreated eggs, but not on the calphostin c-treated eggs, was severely changed. Taken
together, these results suggest that egg PKC activity plays an important role in the
signaling regulation of sperm-egg membrane binding and fusion during fertilization.
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Introduction
Sperm-egg membrane binding and fusion is a critical event, initiating the
development of a new life, but the molecular signaling pathways governing this event are
barely explored. The protein kinase C (PKC) signaling pathway has been shown to play an
important role in diverse cellular processes, such as, cell differentiation, cell growth, and
cell death (3, 43, 62, 89). In addition to these essential roles, oocyte maturation and egg
activation are also regulated by PKC activity (27). There are four broad PKC subfamilies
consisting of 13 isoforms; conventional PKC (cPKC; PKCα, PKCβ, and PKCγ), novel
PKC (nPKC; PKCδ, PKCε, PKCη, and PKCθ), atypical PKC (aPKC; PKCζ, PKCι, and
PKCλ), and PKC-related kinase (PRK) (62). These four subfamilies have different modes
of regulation for their activity. Each activator binds to the regulatory domains of the target
PKC isoforms, which allows the substrate to bind with catalytic domain of the PKC.
cPKC requires 1,2-diacylglycerol (DAG) and calcium ion (Ca2+). nPKC requires DAG or
phorbol esters. aPKC requires Phosphatidylserine. PRK requires Rho (3,62, 89). Rho is a
family of GTP-binding proteins and modifies the actin cytoskeleton (9). A variety of PKC
isoforms, have been confirmed in mouse eggs (28, 58).
Ca2+ inside the egg is also an important signaling molecule. Germinal vesicle stage
mouse oocytes do not continue maturation to pronuclear formation after Ca2+ chelation (5).
The Ca2+ level inside the egg is dramatically increased after fertilization with sperm (67),
leading to cortical granule exocytosis (CGE) at the point of sperm fusion (49, 54, 67).
When eggs are treated with Ca2+ chelator, CGE and second polar body formation are
inhibited (49), and an increase in the number of polyspermy is observed (61). Both Ca2+
independent PKC, and Ca2+ dependent PKC are involved in early egg activation (85).
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These data suggest that the increase in Ca2+ concentration is probably related to the PKC
signaling inside the eggs, stimulaing maturation and activation of mouse oocytes.
In the present study, we particularly focus on the egg PKC activity relevant to
fertilization. PKC activity constitutes the necessary signaling pathway for the egg just
before and immediately after fertilization. Moreover, PKC is recruited to the inner cell
membrane in order to be activated inside the cell (3, 43, 62, 89).

Accordingly, we

hypothesize that PKC is a requirement for sperm-egg membrane binding and fusion. To
test this, the effects of PKC activation and inhibition were examined. Eggs were treated
with either a PKC activator or a PKC inhibitor before insemination, and then the egg’s
ability to fertilize was assessed. Staurosporine and calphostin c (PKC inhibitors), and
PMA (a PKC activator), were applied. Staurosporine inhibits protein kinases, such as,
protein kinase A (PKA), PKC, and protein kinase G (PKG) (39). Calphostin c competes
and binds with DAG and phorbol ester binding sites (31), inhibiting the classic PKC
isoforms (4, 12, 31, 56, 77). PMA is a phorbol ester required for activating classical PKC
isoforms (cPKC, nPKC, and aPKC) (62). Both Ca2+ dependent and independent PKCs are
activated by PMA (2, 95).
PKC is involved in and regulates many signaling pathways in a variety of cell types
(3, 43, 62, 87, 89). We speculate that this drug-altered activity in the egg also leads to
cellular responses other than fertilization events. Actin, CD9, and chromosomal DNA are
known as important molecules involved in egg activation and maturation (61, 20, 46, 63,
69). Actin is a main component of the cytoskeleton and plays various functions in the cell.
These functions include strengthening the cell, organizing the organelles, and controlling
cell division (48, 94). In the egg, actin has been shown to function in the adhesion of
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sperm to the egg and the formation of a polyspermy shield (61, 90). The actin polymer, Factin is easily stained by phalloidin conjugated with a labeling dye, rhodamine.
CD9 is associated with microvilli, and is the only egg membrane protein which is
confirmed as a required molecule for sperm-egg fusion (46, 63). Eggs from CD9 knockout
female mice or those treated with the CD9 monoclonal antibody KMC8 are not able to fuse
with sperm. In somatic cells, translocation of cPKC to the plasma membrane forms a
physical association with CD9 (98). These data suggest that PKC may associate with and
regulate CD9’s function, which, in turn, regulates the egg’s fertilization ability. It is our
hypothesis that changes in the localizations and/or structures of actin, CD9, chromosomal
DNA, and microvilli will be observed after PKC activation or inhibition. By analyzing the
cellular dynamics of these molecules, we will determine the importance of PKC signaling
in fertilization.
In this study, to test the effects of PKC signaling, the egg surface and some
molecules involved in the egg fertilization and activation are examined after PKC
activation/inhibition.

Methods and Materials
Collection of eggs and sperm cells
MII phase oocytes were isolated from 8 to 10 weeks old ICR (65) mice into 100 µl
of M199 Medium containing 0.3 % bovine serum albumin (BSA; Medium 1). Female
mice were superovulated by intraperitoneal injection of 10 i.u. (100 µl of 100 i.u./ml) of
pregnant mares’ serum gonadotropin (PMSG) into female mice. After 48 hours, 10 i.u.
(100 µl of 100 i.u./ml) of human chorionic gonadotropin (hCG) was injected
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intraperitoneally. Approximately 13-14 hours post-hCG injection, mice were sacrificed by
suffocation (CO2 incubation in a plastic box at room temperature) for 2 minutes. The
oocytes surrounded by cumulus cells were obtained from the oviducts. Hyaluronidase
(300 µg / ml) treatment for 5 minutes was used to release the cumulus masses, followed by
chymotrypsin (30 µg / ml) treatment for 3 minutes to remove the zona pellucida from the
oocytes. Using a zona-pipette (appendix A), we applied physical pressure to the zona
pellucida to obtain zona-free eggs. These zona-free eggs were stored in 100 µl of Medium
1 at CO2 incubator (37 °C, 5% CO2). A mouth pipette was used to transfer the eggs in the
in vitro fertilization experiments. After each drug treatment, the eggs were washed three
times with 100 µl of Medium 1 (appendix A). All drug treatments were completed in
Medium 1.
After 8 to 12 weeks male mice were sacrificed by suffocation, caudal epididymis
and vas deferens were obtained. Sperm were isolated from the caudal epididymis and vas
deferens by placed and chopped in 500 µl of M199 Medium with 3 % BSA (Medium 2).
The concentration of sperm in the medium was approximately 1 × 107 sperm / ml after
sperm isolation from one male mouse. Because the sperm acrosome reaction is required
before sperm fusion to the egg (75), sperm were capacitated (changes that enable sperm to
undergo both the acrosome reaction and hyperactivation.) for two hours in 500 µl of
Medium 2 in the CO2 incubator. Sperm were diluted (1:10) from the original concentration
to get the sperm concentration at 1 × 106 sperm / ml.

Drug Treatments of the eggs
All drugs used in this experiment are dissolved in dimethyl sulfoxide (DMSO).
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Therefore DMSO treatment is used as the control group. After a 60 minutes resting
interval, zona-free eggs were incubated with 1 µM calphostin c or 1 % DMSO in 100 µl of
Medium 1 for 60 minutes. After three times washing with Medium 1, eggs were incubated
with DAPI for 15 minutes and washed three times. The same procedure was applied to
staurosporine and PMA treatments.

In Vitro Fertilization (IVF)
Ten µl of sperm (1 × 106 sperm / ml) from the capacitated medium were transferred
into 100 µl of Medium 1 containing the drugtreated eggs (10:110 dilution of the sperm:
approximately 1 × 105 sperm cells in the insemination medium). Fourty minutes after
insemination, eggs were washed three times with Medium 1 to remove nonspecific sperm
binding. Eggs were then fixed with 3.7% formaldehyde for 15 minutes and observed
under 200 × magnification. Sperm binding numbers and fusion numbers were counted.
Under the phase contrast mode, the sperm tails attached to an egg were counted and
defined as the sperm binding number (SB). Under the fluorescence mode, the number of
chromosomal DNA stained with DAPI, excluding the egg chromosomal DNA, was defined
as the sperm fusion number. The fertilization rate (FR) was defined as the percentage of
the eggs fused with at least one sperm. The fertilization index (FI) was defined as the
mean number of fused sperm per egg.
At least 15 eggs per sample group were prepared to normalize the each result. We
repeated the IVF assays with calphostin c for five times, staurosporine for four times, and
PMA for three times. Eggs and sperm were stored in a CO2 incubator (37 °C and 5% CO2)
during all incubation steps.
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Staining and immunocytochemistry of eggs by fluorescence microscopy (Triple staining)
After individual drug treatment, eggs were stabilized on a glass slide by incubation
in M199 Medium without BSA for 30 minutes in a CO2 incubator. Once the eggs were
stacked on the glass, they were treated with 3.7 % formaldehyde in Medium 1 for 15
minutes. After fixation, they were incubated with rat anti-CD9 monoclonal antibody
(KMC8; 50 ug/l final concentration) for 60 minutes and it is washed out though Medium 1
for three times, followed by the incubation with the goat anti-rat IgG antibody (20 ug/l)
conjugated with FITC for 45 minutes. Then they were washed three times with Medium 1
and soaked in 1 % DAPI for 15 minutes to stain the chromosomal DNA and washed three
times with Medium 1. Subsequently, the eggs were treated with 0.1 % triton-X 100 for 1
minute to permeabilize the membrane and washed three times with Medium 1. Finally, the
eggs were incubated with rhodamine-phalloidin (2 ug/ml) for 15 minutes to stain the actin
cytoskeleton and washed three times with Medium 1. The eggs were kept in Medium 1 at
all times during these steps. Fluorescent signals of chromosome (blue), actin (red), and
CD9 (green) were visualized under fluorescence microscopy.

Scanning Electron Microscopy (SEM)
Following each drug treatment, eggs were transferred on to a glass slide holding 50
µl of M199 Medium without BSA. After 30 minutes incubation in the CO2 incubator, eggs
were stabilized on the glass. Eggs were fixed with a 2.5 % glutaraldehyde solution (in 0.1
M sodium cacodylate, pH 7.3) overnight, and then treated with a 1 % osmium tetroxide
solution (in 0.1 M sodium cacodylate, pH 7.3) for 1 hour. After washing with 0.1 M
sodium cacodylate, the eggs were dehydrated by serial ethanol dehydrating steps (50 %,
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The eggs were soaked in each

concentration of ethanol for 15 minutes. The ethanol concentration was increased step by
step. Dehydration with 100 % ethanol was repeated three times to completely dehydrate
the sample. The slide was put into a plasma coater, and sputter coated with gold /
palladium in argon gas. The coated eggs were examined under SEM with a magnification
of 3,500 × or15,000 × to observe the plasma membrane surface of the egg.

Results
IVF after PKC inhibition and activation
A. PKC inhibition
Because all drugs used in this study were dissolved in DMSO (table. 2-1), DMSOtreated eggs were always used as the control group to compare with the eggs treated with
the drugs. From the previous studies, 1 % DMSO treatment on eggs has no effect on the
egg’s fertilization ability (16, our unpublished results). After PKC inhibition by 1 µM of
calphostin c, sperm binding and fusion numbers were significantly decreased (Fig. 2-1).
We observed a clear difference between DMSO and calphostin c treated eggs under the
fluorescence microscope (Fig. 2-5). On the other hand, even though there was a significant
decrease of FR, FI, and SB after the staurosporine treatment (Fig. 2-2), this decrement was
not as dramatic as that seen in the calphostin c treatment.
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Drug Name

Activator / Inhibitor

Target PKC isoforms

Stock Concentration

Calphostin c

Inhibitor

cPKC, nPKC, aPKC

100 µM

DiC8

Activator

cPKC, nPKC

5 mM

Gö 6976

Inhibitor

cPKC, PKCγ, PRK

100 µM

Gö 6983

Inhibitor

cPKC, nPKC, aPKC

100 µM

PMA

Activator

cPKC, nPKC

200 nM

Staurosporine

Inhibitor

cPKC, nPKC, aPKC

100 µM

Y-27632

Inhibitor

PRK

200 µM

Table 2-1. Characteristic and stock concentration of drugs used in this experiment.
Depending on the drug, its strength for the effective concentrations are different, so
their stock concentrations were also different (71, 96).

To determine the efficiency of PKC inhibition by calphostin c, treatments with
different time increments (15, 30, and 60 minutes) were tested. The same inhibition effects
were observed for all treatments at 15, 30, and 60 minutes (Fig. 2-6). Since 30 minutes
treatment effectively inhibited both SB and FR (Fig. 2-6), eggs were treated with
calphostin c for 30 minutes instead of 60 minutes hereafter. To determine whether the
inhibition of calphostin c was dose-dependent, different concentrations of calphostin c (100
nM, 500 nM, and 1 µM) were tested. Sperm binding numbers and fusion rates were both
decreased as the inhibitor concentration was increased (Fig. 2-7), suggesting that the
inhibition effect of calphostin c on the egg’s fertilization ability is dose-dependent and
specific.
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Because there was significant blockage of sperm binding and fusion in the
calphostin c treated eggs, we want to know which PKC isoform(s) have an important role
in the regulation of these fertilization steps. For this purpose, we used three other PKC
inhibitors to treat the eggs before IVF: (R)-(+)-trans-4-(1-Aminoethyl)-N-(4-Pyridyl)
cyclohexanecarboxamide

dihydrochloride

(Y-27632),

12-(2-Cyanoethyl)-6,7,12,13-

tetrahydro-13-methyl-5-oxo-5H -indolo(2,3-a) pyrrolo(3,4-c)-carbazole (Gö 6976), and 2[1-(3-Dimethylaminopropyl)-5- methoxyindol-3-yl]-3-(1H-indol-3-yl) maleimide (Gö
6983). Each drug has a unique target site, therefore, inhibiting different PKC isoforms (31,
77). Y-27632 effectively inhibits Rho-dependent protein kinases, ROCK-I, ROCK-II, and
PRK2 (17, 89). Gö 6976 is competitive to the ATP binding site of Ca2+-dependent PKC
(33), so it selectively inhibits cPKC (7, 17, 33, 77). Gö 6983 inhibits all PKC isoforms
except PKCµ (34, 88); this drug is useful to differentiate PKC µ activity from other PKC
activities. Gö 6976 (1 µM; targets cPKC) and Gö 6983 (1 µM; targets cPKC, PKCδ, and
PKCζ) were used, instead of calphostin c, to inhibit different PKC isoforms in the egg.
Surprisingly, we did not see any inhibition in sperm binding and fusion (Fig. 2-4). Further
experiments are needed to address this discrepancy. However, we did find an interesting
result. After eggs were treated with 2 µM of Y-27632, the polyspermy percentage (the
percentage of the eggs with more than one fused sperm) was significantly reduced to 30.7
± 17.1 %, compared with the control’s polyspermy percentage of 69.2 ± 11.3 % (n=4, p <
0.02).

B. PKC activation
To determine the regulation of fertilization by PKC signaling, a PKC activator was
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applied to the eggs and their fertilization ability was observed. Surprisingly, as we saw in
the eggs treated with either calphostin c or staurosporine, the eggs treated with 2 nM of
PMA showed significant blockage of sperm binding and fusion to an egg. FR, FI, and SB
were all significantly reduced (Fig 2-3). Time-course experiments showed that the PMA
treatment significantly inhibited sperm binding and fusion after 30 minutes treatment (Fig.
2-6). The dose-response curve clearly demonstrated that the treatment with 1 nM of PMA
for 30 minutes effectively decreased the SB and FR (Fig. 2-7). Since PKC activation in
eggs by PMA showed dramatically reduced sperm binding and fusion, another broad PKC
activator, 1,2-Dioctanoyl-sn-glycerol (DiC8) was also tested. DiC8 mimics phorbol esters,
which are required for activation of classical PKC isoforms (34). Eggs treated with 50 µm
of DiC8 for 30 minutes did not show any significant changes in all FR, FI, and SB (Fig. 23). Some eggs were lysed in the medium, and others became very fragile and lysed when
transferred (table 2-2). Increasing the concentration of DiC8 to 100 µM even caused
higher percentage of egg death (103 out of 156 eggs died, 66 %).
concentration of DiC8 will be tested in the future.
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Hiroto Akabane

30

A

90%

76%

80%
Ferilization Rate (FR)

5/3/2006

70%
60%
50%
40%
30%
p<0.001

20%

6.0%

10%
0%

DMSO

calphostin c

B

1.80
Fertilization Index (FI)

1.60
1.40

1.27

1.20
1.00
0.80
0.60
0.40

p<0.01

0.20
0.00

0.066
DMSO

calphostin c

C

7

Sperm Binding (SB)

6

5.48

5
4
3
2
p<0.0001

1
0

0.34
DMSO

calphostin c

Hiroto Akabane

31

5/3/2006

Figure 2-1. Fertilization rate, fertilization index, and sperm bound of DMSO- and
calphostin c-treated eggs. After 1 µM calphostin c treatment, the eggs lost the ability to
bind and fuse with sperm. FR, FI, and SB all were significantly decreased after either the
calphostin c treatment or the PMA treatment.

(A) FR of these two groups. The values

were 75.6 ± 9.6 % (DMSO) and 6.0 ± 3.4 % (calphostin c) (p < 0.001). (B) FI of these two
groups. The numbers were 1.27 ± 0.34 (DMSO) and 0.066 ± 0.036 (calphostin c) (p <
0.01). (C) SB of those two groups, 5.48 ± 0.81 (DMSO), 0.34 ± 0.15 (calphostin c) (p <
0.001).
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Figure 2-2. Fertilization rate, fertilization index, and sperm bound of DMSO- and
staurosporine-treated eggs. After 1 µM staurosporine treatment, the eggs’ ability to bind
and fuse with sperm was drastically decreased. There were significant differences between
the DMSO and staurosporine group in all three values of FR, FI, and SB. (A) FR of these
two groups. The values were 58.8 ± 7.4 % (DMSO) and 24.8 ± 3.3 % (staurosporine) (p <
0.005). (B) FI of these two groups. The numbers were 0.79 ± 0.22 (DMSO) and 0.26 ±
0.06 (staurosporine) (p = 0.04). (C) SB of those two groups, 9.62 ± 2.22 (DMSO) and 3.83
± 1.15 (staurosporine) (p = 0.03).
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Figure 2-3. Fertilization rate, fertilization index, and sperm bound of DMSO- and PMAtreated eggs. After 2 nM PMA treatment, the eggs lost the ability to bind and fuse with
sperm. FR, FI, and SB all were significantly decreased after the PMA treatment. (A) FR
of these two groups. The values were 71.0 ± 12.9 % (DMSO) and 2.2 ± 2.2 % (PMA) (p <
0.005). (B) FI of these three groups. The numbers were 1.19 ± 0.33 (DMSO) and 0.03 ±
0.02 (PMA) (p < 0.01). (C) SB of those three groups, 9.82 ± 3.33 (DMSO) and 0.81 ±
0.17 (PMA) (p < 0.01).
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Figure 2-4. Fertilization rate, sperm bound, and fertilization index to the eggs treated with
DMSO, Gö 6976, Gö 6983, or DiC8. There were not significant differences between
DMSO and drug treatment groups in all three values of FR, FI, and SB. (A) FR of these
four groups. The values were 75.6 ± 3.2 % (DMSO), 77.9 ± 1.2 % (Gö 6976), 73.2 ±
2.5 % (Gö 6983), and 75.0 ± 3.8 % (DiC8). (B) FI of these four groups. The numbers
were 1.32 ± 0.11 (DMSO), 1.73 ± 0.20 (Gö 6976), 1.18 ± 0.08 (Gö 6983), and 1.13 ± 0.32
(DiC8). (C) SB of those four groups, 6.56 ± 0.67 (DMSO), 8.64 ± 2.68 (Gö 6976), 8.09 ±
0.76 (Gö 6983), and 6.09 ± 0.22 (DiC8).
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Figure 2-5. Microscopic images of the DMSO-treated (A and B) and calphostin c-treated
(C and D) eggs. The phase contrast image of DMSO-treated eggs (A) shows many sperm
binding (SB) to the eggs. In contrast, no SB is seen in the phase contrast image of
calphostin c-treated eggs (C). Blue dots show chromosomal DNA stained by DAPI in the
fluorescence image of the DMSO-treated eggs (B) and the calphostin c-treated eggs (D).
More than two dots are observed in each egg in picture B, but all eggs have only one
chromosomal DNA dot in picture D. This means that there is no sperm fusion to the eggs
treated with calphostin c. Polyspermy eggs with three or more blue dots (indicated by
arrows) are also observed in picture B.
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Figure 2-6. Changes in sperm binding and fusion rate over the time course of 1 µM
calphostin c (A) or 2 nM PMA (B) treatment. As the treatment time increases the SB and
FR decreases. Each tested group contained at least 20 eggs and was repeated three times.
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Figure 2-7. The dose-response curve after 30 minutes exposure to calphostin c (A) or
PMA (B) treatment. SB and FR of the calphostin c-treated eggs gradually decreased as
concentration increased. In contrast, both SB and FR of PMA-treated eggs were suddenly
blocked at 1 nM of PMA. 30 minutes treatments were applied to all experiments. Each
tested group contained at least 20 eggs and was repeated three times.
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B

Figure 2-8. Microscopic images of the eggs after insemination with sperm then followed
by 2 nM PMA treatment for 60 minutes. Egg pictures are of phase contrast (A) and DAPI
fluorescence (B). No sperm tails were observed in picture A, indicating no sperm binding
to the eggs. All eggs showed only egg chromosomal DNA in picture B, indicating no
fusion of sperm to the eggs.
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Treatment

fertilized eggs # fused sperm #

sperm bind #

Total egg #

(40 minutes)

(FR)

(FI)

(SB)

DMSO

138 (72.6 %)

219 (1.15)

1468 (7.73)

190

50 µM DiC8

120 (65.2 %)

210 (1.14)

1477 (8.03)

184

100 µM DiC8

103/156 (66.0 % of eggs lysed)

156

Table 2-2. Fertilization ability of the eggs treated with DiC8. There was no statistical
difference between the DMSO- and DiC8-treated group (P=0.21). The eggs treated with
100 µM DiC8 intent to die in the medium. The egg membrane became delicate to physical
stress.

The transferring procedure broke some cells and movement of the medium

provoked cell lysis.

Localization of chromosomal DNA, actin, and CD9 after PKC inhibition or activation
It is possible that PKC activity regulates the molecules known to have a critical role
in the fertilization process. These molecules include actin, CD9, and chromosomal DNA
(18, 61, 63). Actin is required for further activation of the egg after sperm fusion (61).
CD9 is a tetraspanin protein, and is expressed on the egg’s microvilli. It is required for
sperm fusion (46, 63, 99). Association of egg and sperm chromosomal DNA influences
further steps of egg activation and zygote development.

If PKC is involved in the

regulation of these molecules, both the structure and localization of these molecules could
be changed after PKC inhibition (by calphostin c) or activation (by PMA). Actin, CD9,
and chromosomal DNA were visualized by rhodamine-phalloidin, FITC-conjugated
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secondary antibody, and DAPI respectively. Under fluorescence microscopy, rhodamine,
FITC, and DAPI appear red, green and blue, respectively. A 0.1 % triton X-100 solution
was used to permeabilize the egg membrane so that rhodamine-phalloidin could stain the
actin inside (20, 69). This permeabilization also allowed for the detection of any CD9 in
the cytoplasm, although CD9 is usually found on the egg plasma membrane. Our results
indicated that PKC inhibition by calphostin c did not elicit any changes in the localization
and structure of actin, CD9, and chromosomal DNA (Fig 2-9). The actin meshwork in the
cell cortex (just beneath the cell plasma membrane) and the actin cap (just overlying the
egg chromosomal DNA) were not significantly changed. CD9 was still restricted to the
microvillus region of the egg plasma membrane.

And the egg chromosomal DNA

appeared normally. Similar results were obtained when eggs were treated with 2 nM PMA.
No significant change was seen for actin, CD9 or egg chromosomal DNA.
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C

Figure 2-9. DAPI (A), CD9 (B), and actin (C) staining of an egg after calphostin c
treatment. The arrow in A indicates the chromosome of the egg. The two arrows in B
show the boundaries of the microvilli (major region) and the amicrovilli (minor region) of
the egg surface. CD9 is restricted to the microvillus region. The two arrows in C show the
actin cap of the egg. Similar staining patterns of DAPI, CD9 and actin were observed in a
control egg.

SEM imaging of the egg
After calphostin c or PMA treatment, eggs lost their ability to be fertilized with
sperm. This result may come from the regulation of the microvillus structure on the egg
surface by PKC activity. Microvilli physically permit sperm to bind with the egg (25).
PKC may negatively modify this structure so that the egg is not able to bind with sperm.
To approach this question, we used electron microscopy to visualize this structure on the
egg membrane. Because we used toxic chemicals to fix the egg, i. e. paraformaldehyde
and osmium, mouth pipetting was not used for transferring eggs. Therefore, the eggs were
attached to a glass slide so that we could change the solution, instead of transferring the
eggs. We made sure that the eggs had stuck on to the glass before fixation, otherwise eggs
would not attach to the glass after fixation. BSA in the routine culture medium does not
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allow the living eggs to attach to the Petri dish or the slide glass. Thus, we established a
protocol that 30-minutes incubation of the eggs in M199 without BSA successfully
attached the eggs on the slide glass. In this way, the eggs would not be drained off the
slide glass when the solution was changed with a pipette. After fixation, dehydration, and
coating with gold, the eggs were observed under SEM. Normal microvillus structure and
an amicrovillus region were clearly seen on the surface of the egg (Fig 2-9). There was no
difference between the calphostin c-treated egg and the control egg in both 3,500 × and
15,000 × magnifications.

On the other hand, there was a dramatic change on the

microvillus structure of the PMA treated egg. The microvillus number was obviously
reduced

and

the

microvilli

shape

became

distinctly

longer

and

bigger.

Hiroto Akabane

47

A

B

C

D

E

F

5/3/2006

Hiroto Akabane

48

5/3/2006

Figure 2-10. Scanning electron microscopy (SEM) images of the drug-treated eggs. The
egg samples were observed with two magnifications, 3500 X (A, C, E) and 15,000 X (B, D,
F). Eggs treated with DMSO showed normal microvillus structure (A, B). Calphostin ctreated eggs also showed normal morphology of the microvillus and amicrovillus (arrow in
C) regions (C, D). An unusual microvillus structure was found on the egg surface after
PMA treatment (E, F). The microvillus number was reduced and its shape became longer.

Discussion
Several findings are revealed from the series of experiments in this study. As was
hypothesized, PKC activity in the mouse egg is involved in the signaling regulation of the
egg-sperm membrane binding and fusion. Surprisingly, we find that both inhibition and
activation of PKC in mouse eggs results in the blockage of sperm binding and fusion,
suggesting that PKC activity in eggs may be precisely balanced to regulate gamete
membrane interaction in a biphasic mode. Under fluorescence microscopy, PKC inhibition
by calphostin c or activation by PMA did not affect the structure and localization of actin,
CD9, and chromosomal DNA in the egg. These molecules play an important role during
fertilization and development of the egg (20, 46, 48, 61, 63, 69,90, 94). Interestingly,
under scanning electron microscopy, the structural morphology of egg surface microvilli
was severely altered in the PMA-treated eggs, but not in the calphostin c-treated eggs.
Both PKC inhibitors, calphostin c and staurosporine, significantly disrupted the
egg’s ability to bind and fuse with sperm. Staurosporine is the non-specific PKC inhibitor
and targets many other protein kinases (15). Therefore, compared with calphostin c, it is
expected that 1 µM staurosporine treatment was not as effective as 1 µM calphostin c
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treatment. Indeed, the reduced level of FR, FI and SB in the staurosporine-treated eggs
was less than those in the calphostin c-treated eggs. Moreover, calphostin c induces
irreversible PKC inhibition (31), whereas staurosporine induces a competitive and
reversible PKC inhibition (78). Different extent of decrease in SB and FR after these two
drug treatment could be explained by these characteristics. It is anticipated that there is
still some PKC available for the eggs when they are treated with staurosporine. When
there is PKC available in the egg cytoplasm, egg would still hold or recover the ability for
fertilization.
By examining the time-course and dose-response of the calphostin c treatments, we
found out that 1 µM calphostin c treatment for 30 minutes was required to cause significant
inhibition of sperm binding and fusion to the egg. A shorter treatment time or a lower
concentration was not able to significantly block fusion and binding of sperm. Although
some structural or localization alterations of actin, CD9, chromosomal DNA, or microvilli
were expected, no changes were observed under fluorescence microscopy and SEM.
Signaling pathways that block sperm binding or fusion to the egg might be turned on or
signaling pathways that prompt SB and FR might be turned off after PKC inhibition by
calphostin c. Consequently, PKC inhibition by calphostin c in mouse eggs specifically
leads to the shut-down of sperm binding or fusion without altering other known molecules
involved in sperm fusion and binding to the egg. Strangely enough, other kinds of specific
PKC inhibitors, Gö 6976 and Gö 6983, had no effect on the egg’s ability for fertilization
with sperm. Concentrations and treatment times applied for both drugs in this study were
considered to effectively inhibit target PKC isoforms in mouse eggs.

This was also

indicated in other studies (7, 17, 33, 34, 77, 88), in which many cell lines from several
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species were tested. The reasons for this inconsistency are not clear at this moment and
will be further investigated.
In our hands, fertilized eggs normally show more than 60 % polyspermy rate after
IVF. Interestingly, we found that only 30 % of the eggs treated with 2 µM Y-27632
showed polyspermy. Y-27632 is a very specific inhibitor of Rho-dependent protein kinases
(17), and shows low suppression of other kinases. Accordingly, it is possible that Rhodependent protein kinases inhibited by this treatment are responsible for the reduced
polyspermy rate. Because SB and FR were not changed, it seems that the Y-27632
treatment specifically blocked the second sperm from fusing. There is a time lag between
the first sperm fusion and the egg mechanism that refuses the second sperm. Harmonious
sperm fusion after sperm binding may be assisted by Rho-dependent protein kinases.
Therefore, it would be intriguing to see whether Rho-dependent protein kinases play a role
in facilitating the transition of sperm binding to sperm fusion.
One remarkable observation about two PKC inhibitors (Gö 6976 and Gö 6983) was
that the treated eggs seemly underwent immediate egg activation to form the second polar
body after 40 minutes fertilization with sperm (Fig. 2-10). 40-50 % of fertilized eggs
experienced this abnormal activation. Unfertilized eggs did not display this abnormal
activation. This instant activation was not seen in the other IVF experiments, such as in
the treatments of calphostin c, PMA, and DiC8. In the previous studies, this phenomenon
was observed 1-2 hours after insemination and pronucleus formation was confirmed 8
hours after PKC inhibition (2 µM staurosporine) and activation (PMA and DiC8) (54, 57).
In this study, both zona-free and zona-intact eggs treated with either Gö 6976 or Gö 6983
did not experience pronucleus formation even after 8 hours without sperm fertilization.
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Since both 1 µM Gö 6976 and 1 µM Gö 6983 effectively inhibit Ca2+ dependent PKC
isoforms, cPKC, there are two possibilities considered. The rapid activation of MII phase
oocytes is either induced by cPKC inhibition or suppressed by cPKC activity.
Nevertheless, it is difficult to conclude that only the cPKC isoforms, which are also
inhibited by calphostin c, control the second polar body emission. Moreover, it is stated
that spindle stability and high maturation promoting factor (MPF) activity are required for
the MII arrest of mouse oocytes (10). Thus these drugs may affect and change microtubule
stability or MPF activity, because they have potent actions other than PKC inhibition (17,
77). Not only the PKC family, but other kinases are also inhibited or activated by these
drugs. The significance of the observation that Gö 6976- and Gö 6983-treated eggs
immediately emitted the second polar body after fusion with sperm remains to be
addressed.

Figure 2-11. Phase contrast image of inseminated eggs treated with1 µM Gö 6976. The
arrows show the egg’s abnormal shape, which indicates an extrusion of the second polar
body from the egg. This event was induced only by Gö 6976 and Gö 6983 in this study.
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The eggs treated with PMA showed similar reduction in sperm binding and fusion
as the eggs treated with calphostin c. One remarkable difference between these two drugs
is that the structure of microvilli on the egg surface was drastically changed after the PMA
but not calphostin c treatment. This alteration of microvilli on the egg is considered to be
the reason for the decreased sperm binding and fusion. From the previous data, PMA
treatment induced pronuclear formation in both GV oocytes and MII phase eggs. It is
anticipated that PKC activity controls the pronuclear formation, or egg activation into an
embryo, in mouse eggs (58). We speculate that this promotion of eggs’ maturation and
activation, eventually, might establish a sperm fertilization blocking system inside the egg,
such as the alteration of the microvillus structure as seen in this study.
Even though DiC8 treatment induced pronuclear formation in the previous report
(58), normal sperm binding and fusion was observed in this study. PMA induces the
structural change of egg microvilli, which blocks sperm binding and fusion rapidly.
However, DiC8 may not quickly enough induce the microvillus change on the egg surface.
Different from DiC8, PMA activates ATPase and promotes cAMP formation (2, 95). This
ATP regulation could also modulate the egg’s fertilization ability.
Calphostin c treatment gradually reduced sperm binding and fusion to the egg.
However, PMA treatment suddenly destroyed the egg’s ability to bind and fuse with sperm.
This result suggests that there might be a threshold of PKC activity. Increase of PKC
activity to a certain level may switch on a blocking system, which in turn totally inhibits
fertilization of the egg. With this respect, we speculate that the level of PKC activity
activated by 1 nM PMA is equivalent to that activated after sperm fusion to the egg.
In summary, our results show that the eggs treated with both PKC activation and
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inhibition significantly decreased their fertilization ability to bind and fuse with sperm.
PKC inhibition by calphostin c significantly reduces sperm binding and fusion to the egg.
However, this treatment does not affect the egg’s viability and activation (this study and
57), nor does it shift the distribution of actin, CD9, chromosomal DNA, and microvilli. On
the other hand, PKC activation by PMA not only remarkably reduces sperm binding and
fusion to the egg, but also markedly alters the number and shape of microvilli on the egg
membrane, even though no distinct changes were observed for the localization and
structure of actin, CD9 and chromosomal DNA. Taken together, these results suggest that
PKC activity in eggs may be precisely balanced to regulate gamete membrane interaction
in a biphasic mode, and this biphasic regulation is executed through two different
mechanisms.
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Chapter Four
Conclusions
1. PKC inhibition by calphostin c or staurosporine in the mouse egg significantly
diminished sperm fusion and binding. Calphostin c did not change the microvillus
structure on the egg surface which is considered as a critical structure for spermegg membrane binding. The data from dose-dependent curve showed that the
higher concentration of calphostin c treatment resulted in the less sperm binding
and fusion to the egg. Collectively, these results sustain that PKC activity in the
egg is necessary for sperm-egg membrane binding and fusion, highlighting that the
PKC signaling plays a critical role during fertilization of the mouse egg and sperm.

2. PKC activation by PMA in the mouse egg significantly decreased sperm fusion and
binding. Moreover, this treatment also markedly changed the structure of the
microvilli on the egg surface. PKC activation in the mouse egg is known to induce
egg activation. In addition, the dose-response curve from this study shows sudden
decrease in sperm binding and fertilization rate between 500 pM to 1 nM PMA
treatment, suggesting a threshold of PKC activity exists in the regulation of the
egg’s ability to bind and fuse with sperm. Sperm fusion to the egg may create a
polyspermy blocking mechanism involving the microvillus structure.

Taken

together, these data support the important role of PKC signaling in the regulation of
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sperm-egg membrane binding and fusion, a view that has not been appreciated
before.

3. The localization of CD9, actin, and chromosomal DNA in the mouse egg were not
changed by PMA or calphostin c treatment under the protocols described in this
study. It is possible that the regulation of these molecules may require some time
after PKC activation or inhibition. If so, we may miss any changes since these
molecules were detected shortly after each drug treatment.

Alternatively, the

regulation of these molecules may be mediated through other signaling pathways.
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Future Directions
For future studies based on this research results, we can explore more pathways
regulated by PKC signaling inside the mouse oocyte (egg).
Several previous studies report the automatic resumption of meiosis after PKC
activation (57, 58). We found that the PKC- activated egg already compromised the ability
to bind and fuse with sperm. Therefore, it is reasonable to hypothesize that PKC activation
mimics the fertilization of an egg with sperm. However, blockage of sperm binding and
fusion to the egg by calphostin c are not expected. For further understanding of PKC
activity during fertilization, our research focus will be on PKC inhibition, which is still
shrouded in mystery, rather than PKC activation.
PKC signaling activates many other signaling modules, such as extracellular
signal-regulated kinase (ERK), epidermal growth factor (EGF), and mitogen-activated
protein kinase (MAPK) (41, 42, 52, 70). Because this complex signaling network is either
regulating PKC or regulated by PKC, we can explore the signaling pathways downstream
or upstream of PKC.

One previous study showed the involvement of Raf (a

serine/threonine kinase) in oocyte development (14). Raf is also regulated by PKC activity
(40). Accordingly, contribution of the Raf pathway in gamete membrane interaction is
possible and worthy of further investigation.

Designing in vitro fertilization (IVF)

experiments with the activation or inactivation of the Raf pathway inside the egg, we may
clarify the participation of Raf signaling module during fertilization.
Calcium ion is another candidate to examine its function inside the egg during
sperm-egg membrane binding and fusion.

One subfamily of the PKC isoforms,

conventional PKC, requires calcium to be activated, and calcium oscillation is observed
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inside the egg after sperm fusion with the egg. In the previous study, it has been shown
that calcium chelator treated eggs showed polyspermy after IVF (61). Treating eggs with
both a PKC activator and a calcium chelator, we may identify the specific role of calcium
ion during sperm and egg fertilization.

Furthermore, the combination of PKC

activators/inhibitors and calcium ionophore or chelators in the treatment of mouse eggs, we
will be able to investigate the fundamental relationship of PKC and calcium ion during
sperm-egg binding and fusion.
Although this study clearly demonstrates the importance of PKC pathway in the
egg, PKC signaling may also play a role in sperm during sperm-egg membrane binding
and fusion. One paper suggests that the PKC signaling and calcium ion pathway are
required for capacitation of sperm (74).

Instead of treating eggs with PKC

activators/inhibitors, our next research experiments may be designed to investigate these
drugs’ effects on sperm during fertilization. To do so, capacitated sperm will be treated
with a PKC activator or a PKC inhibitor, and then be used in the IVF assays. Sperm may
also be treated with a calcium ionophore/chelator to determine the involvement of calcium
ion during sperm-egg binding and fusion. Crosstalk of PKC and calcium ion will be also
explored. It is our hypothesis that PKC signaling and calcium ion inside the sperm also
play an important role during sperm-egg membrane binding and fusion.
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Appendix A
Detail of Methods
Preparing transfer pipette and zona pipette
Eggs are small (~100 µm), delicate, and low number (80-200 eggs from 6 female
mice) when isolated from a mouse; therefore, we have to use mouth pipettes for fine
adjustment of the pressure to the pipettes. “Transfer-pipette” is used to transfer eggs and
“zona-pipette” is used to remove the zona pellucida from around the eggs. These pipettes
are made by hand in the lab. A 9” disposable Pasteur pipette tip is held and heated in an
alcohol ramp flame until it is red in color. When the pipette becomes red and softens, take
it out of the flame and pull both sides of the pipette. The diameter of a transfer-pipette is
120 - 200 µm, the diameter of a zona-pipette is 50 - 100 µm (Fig. 1). Since they are very
thin and easily broken, extra pipettes are also created.
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Egg
Zona pelucida

120-200 µm

Egg

Zona-pipette

Zona pellucida

50 - 100 µm

Figure Ap-1.
Simple figures of the transfer and zona pipette used for this study. Depending
on the person, the diameter of each pipette will be different.

1 4

2

3

Figure Ap-2.
When a drug is put into drop 1, eggs are washed through 2, 3, and 4 (35 X 10
mm Petri dishes are used). 100 µl of Medium 1 is used to make each drop.
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Data figures
Subsection A: Egg images after IVF in phase contrast and fluorescence
Figure A-1. phase contrast image of DMSO-treated eggs after IVF.
(November 17, 2004)

Figure A-2. fluorescence image of DMSO-treated eggs after IVF.
(November 17, 2004)
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Figure A-3. phase contrast image of calphostin c-treated eggs after IVF.
(November 17, 2004)

Figure A-4. fluorescence image of calphostin c-treated eggs after IVF.
(November 17, 2004)
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Figure A-5. phase contrast image of PMA-treated eggs after IVF.
(November 17, 2004)

Figure A-6. fluorescence image of PMA-treated eggs after IVF.
(November 17, 2004)
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Figure A-7. phase contrast image of Gö 6976-treated eggs after IVF
(February 25, 2005)

Figure A-8. fluorescence image of Gö 6976-treated eggs after IVF
(February 25, 2005)
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Figure A-9. phase contrast image of Gö 6983-treated eggs after IVF
(February 25, 2005)

Figure A-10. fluorescence image of Gö 6983-treated eggs after IVF
(February 25, 2005)
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Subsection B: Localization of actin, CD9, and chromosomal DNA inside
the mouse egg
(June 24, 2004)
Figure B-1. actin
Actin

locatization

after

calphostin

c

treatment. Rhodamine-phalloidin was used to
bisualize actin inside the egg.

Figure B-2. CD9
CD9 localization after calphostin c treatment.
After rat anti-CD9 antibody treatment, FITCconjugated goat anti-rat antibody was used
for immunohistochemistry.

Figure B-3. chromosomal DNA
Chromosomal

DNA

localization

after

calphostin c treatment. DAPI is used to stain
the egg chromosomal DNA.

Hiroto Akabane

79

Subsection C: Scanning Electron Microscopy images of eggs
(March 25, 2004)

Figure C-1. control (DMSO-treated)
egg surface (X 3500)

Figure C-2. control (DMSO-reated)
egg surface (X 15000)
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Figure C-3. calphostin c-treated egg
surface (X 3500)

Figure C-4. calphostin c-treated egg
surface (X 15000)
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C-5.

PMA-treated

egg

C-6.

PMA-treated

egg

surface
(X 3500)

Figure
surface

(X 15000)
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Subsection D: Change in fertilization ability after staurosporine,
calphostin c, and PMA treatment of mouse eggs

Figure D-1. change in FR after PMA treatment of eggs
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Figure D-2. change in FI after PMA treatment of eggs
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Figure D-3. change in SB after PMA treatment of eggs
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Figure D-4. change in FR after calphostin c treatment of eggs
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Figure D-5. change in FI after calphostin c treatment of eggs
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Figure D-6. change in SB after calphostin c treatment of eggs
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Figure D-7. change in FR after staurosporine treatment of eggs
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Figure D-8. change in FI after staurosporine treatment of eggs
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Figure D-9. change in SB after staurosporine treatment of eggs
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Figure D-10. dose-dependent effects of calphostin c to the sperm binding and fusion rate
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Figure D-11. dose-dependenteffects of PMA to the sperm binding and fusion rate
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Figure D-12. time-dependent effects of calphostin c to the sperm binding and fusion rate
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Figure D-13. time-dependent effects of PMA to the sperm binding and fusion rate
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Figure D-14. change in FR after Gö 6976, Gö 6983, and DiC8 treatment of eggs
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Figure D-15. change in FI after Gö 6976, Gö 6983, and DiC8 treatment of eggs
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Figure D-16. change in SB after Gö 6976, Gö 6983, and DiC8 treatment of eggs
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